Cowen Downgrades Regulus Therapeutics (RGLS) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. TFII
6. LYB
7. LITE
8. NVT
9. SPY
10. AAPL

Go back to Cowen Downgrades Regulus Therapeutics (RGLS) to Market Perform

Regulus Reports Third Quarter 2016 Financial Results

November 1, 2016 4:10 PM EDT

LA JOLLA, Calif., Nov. 1, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the three and nine months ended September 30, 2016 and provided a summary of corporate highlights.  

"Our focus in the third quarter included the advancement of the RG-012 development program and addressing the clinical... More